Navigation Links
Hyperion Therapeutics Raises $60 Million Series C
Date:6/30/2009

SOUTH SAN FRANCISCO, Calif., June 30 /PRNewswire/ -- Hyperion Therapeutics, a privately held specialty pharmaceutical company focused on the development of therapies that address critical unmet needs in the areas of gastroenterology and hepatology, today announced it has closed a $60 million Series C financing. New investors Bay City Capital and Panorama Capital co-led the financing. Series A and B investors Highland Capital Partners, NEA, and Sofinnova Ventures also participated.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070905/AQW076LOGO)

The Series C financing follows the Company's recent announcement of Phase II results and orphan drug designation for HPN-100 in its lead indication, the chronic treatment of patients with urea cycle disorders (UCD). The capital will fund the Phase III clinical program for UCD as well as a Phase II study in low grade hepatic encephalopathy.

Concurrent with the Series C financing, H. Daniel Perez, M.D. of Bay City Capital, and Gaurav Aggarwal, M.D. of Panorama Capital have joined the Hyperion Therapeutics Board of Directors.

"Considerable unmet needs remain in the treatment of both urea cycle disorders and hepatic encephalopathy," said Daniel Perez of Bay City Capital. "We believe the Hyperion management team, with their extensive drug development and regulatory expertise, is well positioned to lead a clinical development program focused on potential treatment options for these patients."

About HPN-100

HPN-100 is an investigational product that is a pre-pro-drug of phenylacetic acid, the active moiety of BUPHENYL(R), the only therapy currently FDA-approved as adjunctive therapy for the chronic management of patients with the most prevalent urea cycle disorders: carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), and argininosucci
'/>"/>

SOURCE Hyperion Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis
2. Hyperion Therapeutics Completes Phase 2 Data Analysis and Schedules End of Phase 2 Meeting With FDA for HPN-100 in the Chronic Treatment of Urea Cycle Disorders
3. Hyperion Therapeutics Elects Lota Zoth to Board of Directors
4. Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy
5. Cornerstone Therapeutics Joins the Russell 3000(R) Index
6. Global Autoimmune Disease Therapeutics Market to Reach $50 Billion by 2015, According to a New Report by Global Industry Analysts
7. Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market
8. Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review
9. Prospect Therapeutics Inc.s GCS-100 Has Focused on Developing Treatment for Three Blood-Borne Cancers
10. Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
11. Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... and digital marketing communications company announced today that it has officially launched a ... President, the new website and brand refresh are more closely aligned with the ...
(Date:8/31/2015)... Illinois (PRWEB) , ... August 31, 2015 , ... ... their AdvantaClean franchise business with a ribbon-cutting ceremony on Aug. 26, generously hosted ... calls and booking inspection appointments via AdvantaClean’s National Call Center and website since ...
(Date:8/31/2015)... ... 31, 2015 , ... Physicians’ Education Resource®, LLC (PER®) ... Innovative Cancer Therapy for Tomorrow® meeting, is seeking abstract submissions for its ... City. The annual legacy meeting uses a variety of formats to educate all ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... peers may be at a greater risk for injury, potentially because they are ... University of Pittsburgh Graduate School of Public Health analysis discovered. , The ...
(Date:8/31/2015)... ... August 31, 2015 , ... On Saturday, May 30th, ... at the Adams County Fairgrounds in Mendon, IL. The purpose behind this concert was ... Mendon and neighboring town, Quincy. Best Drug Rehabilitation’s sponsorship of “Music with a Mission” ...
Breaking Medicine News(10 mins):Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3
... really mysterious, however these have inspired a computational technique ... affected by the// personality disorder schizophrenia. Researchers feel the ... that can help diagnose the condition. ,Exactly ... schizophrenia is yet to be pinned down. Raymond Deicken ...
... abuse can be moderately improved by various psychotherapy treatments ... the best clinicians// can hope for at this time, ... behavioral therapy (CBT) is most effective, but other counseling ... social problems associated with their marijuana use. ...
... and Clinical Excellence (NICE) has brought out guidance to ... to help adult patients suffering acute plaque psoriasis. Despite ... benefits for many patients in Europe due to the ... for many thousands of patients across United Kingdom who ...
... research done by Eyal Raz, Sandip Datta and Joshua ... Medicine it was found that gamma radiation// killed bacteria ... against the bacterial disease. ,The U.S. National ... researches in their finding and said that these bacterial ...
... who completed a management course here and agreed to be part ... effects of the trial and is looking// forward to returning to ... trial for US testing firm Parexel in March, but is now ... He is reported to be taking antidepressants and medication to stop ...
... which a specific cell protein trigger the spread of cancer ... by researchers in the Cell Signalling Unit, University of Edinburgh ... which limit the protein's ability to turn a normal cell ... the activity of a key cancer preventing protein called p53. ...
Cached Medicine News:Health News:Diagnosing Schizophrenia 2Health News:Marijuana Abuse Responds to Psychotherapy, Overall Is Hard to Treat 2Health News:Marijuana Abuse Responds to Psychotherapy, Overall Is Hard to Treat 3Health News:NICE supports application of advanced biological therapies as treatment option for acute psoriasis 2Health News:NICE supports application of advanced biological therapies as treatment option for acute psoriasis 3Health News:NICE supports application of advanced biological therapies as treatment option for acute psoriasis 4
(Date:8/31/2015)... BOTHELL, Wash. , Aug. 31, 2015 /PRNewswire/ ... ), the leading developer, manufacturer and marketer of ... storage and cryopreservation freeze media ... chain management app for smart shippers ... its customer TiGenix NV, an advanced biopharmaceutical company ...
(Date:8/30/2015)... LONDRES, August 30, 2015 ... de l cuidado al paciente ... trayecto   Royal Philips  (NYSE: ... de IntelliSpace Cardiovascular , un sistema web de ... para acceder, analizar y compartir imágenes cardiovasculares e información ...
(Date:8/28/2015)... 28, 2015  Delays in the launch and ... down the decision-making process, resulting in missed opportunities ... for biopharmaceutical companies to develop a tactical approach ... quicker and more meaningful insights. ... nearly three-quarters of benchmarked study participants use review ...
Breaking Medicine Technology:BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Expediting the Pharmaceutical Market Research Process for Faster Insights 2
... is encouraged by the steps FDA is taking ... so many patients with hematololgic malignancies under our ... with the Society,s recommendations to FDA, Congress, and ... to prevent drug shortages by requiring manufacturers to ...
... Electronic health records and embedded tools can alert ... weight of children and teenagers, according to a new ... of Pediatrics . Researchers analyzed visits for ... to evaluate the impact of computer-assisted decision tools and ...
Cached Medicine Technology:Statement from American Society of Hematology (ASH) President Armand Keating, MD, on FDA Action to Alleviate Drug Shortages 2Computer-Assisted Tools Alert Pediatricians to Obese Patients 2Computer-Assisted Tools Alert Pediatricians to Obese Patients 3Computer-Assisted Tools Alert Pediatricians to Obese Patients 4Computer-Assisted Tools Alert Pediatricians to Obese Patients 5
Ideal for abdominal procedures...
For lipoplasty of trochanteric region, abdomen, thighs, hips/flanks, buttocks, knees, calves and ankles...
CDIs original garments with our exclusive Wonderfabric™....
Short Girdle, Mid-thigh, Front Closure...
Medicine Products: